Studies show ProtoKinetix's AAGP maintains cell integrity and function

By Lisa Kerner

Erie, Pa., Feb. 15 - ProtoKinetix, Inc. said results of a study on the effects of AAGP (a synthetic age-arresting glycoprotein) on cellular growth and function suggest "that AAGP does not affect cellular integrity or cause any abnormal effects."

Previous results demonstrated AAGP protective activity against harsh stress (such as H2O2 exposure and UV-C radiation) even at low concentrations, according to a company news release.

ProteoCell Laboratories completed a group of trials to test for possible adverse effects of extended exposure to AAGP. The results indicated that AAGP does not affect cell growth or cell protein secretion or activity, the company said.

ProtoKinetix is a scientific development company based in Vancouver, B.C.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.